From NASH to HCC: current concepts and future challenges

By Q. Anstee, H. Reeves, E. Kotsiliti, O. Govaere, M. Heikenwalder. Nature reviews: Gastroenterology & hepatology, 2019

1,223 citations recorded by the source corpus.

Subfields: Cell Biology, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/ecc5c12857f3a9c6f4fcd2e4d5b2b14dfa67257d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

1. Gerald I. Shulman
2. S. Friedman

In Endocrinology, Diabetes and Metabolism

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba

In Epidemiology

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba
4. Y. Saiman
5. J. Puche
6. J. Bonner
7. D. Clegg
8. B. Palmer

Citations in the corpus

• Mechanisms and disease consequences of nonalcoholic fatty liver disease (2021, background): “TLR4 signaling in macrophages and stellate cells, for example, provokes inflammasome activation in both cell types, which is proinflammatory and fibrogenic (Anstee et al., 2019; Dong et al., 2020; Nguyen et al., 2018; Sharifnia et al., 2015).”
• Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies (2024, background): “472,473 A recent study has revealed that ferroptosis stands out as the most pertinent form of hepatocyte death, leading to HCC-promoting necroin fl ammation and compensatory proliferation.”